{"name":"Pharmanutra S.p.a.","slug":"pharmanutra-spa","ticker":"","exchange":"","domain":"pharmanutraspa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ferric Maltol (Feraccru®)","genericName":"Ferric Maltol (Feraccru®)","slug":"ferric-maltol-feraccru","indication":"Iron deficiency anemia in adults with chronic kidney disease","status":"marketed"}]}],"pipeline":[{"name":"Ferric Maltol (Feraccru®)","genericName":"Ferric Maltol (Feraccru®)","slug":"ferric-maltol-feraccru","phase":"marketed","mechanism":"Ferric maltol is an iron-carbohydrate complex that provides bioavailable iron to treat iron deficiency anemia by replenishing iron stores.","indications":["Iron deficiency anemia in adults with chronic kidney disease","Iron deficiency anemia in patients with inflammatory bowel disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}